Results 121 to 130 of about 86,557 (257)

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

Advanced NanoBiomed Research, EarlyView.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi, Md Mijanur Rahman, Asma Talukder, Urooj Yousaf Virk, Jennifer C. Wilson, Nigel McMillan, Ming Q. Wei   +6 more
wiley   +1 more source

Asymptomatic esophageal eosinophilia in oral immunotherapy: context and clinical application. [PDF]

J Allergy Clin Immunol Pract
Wright BL, Doyle AD.
europepmc   +1 more source

Cassava oral immunotherapy in cassava-latex allergy: A pilot study. [PDF]

J Allergy Clin Immunol Glob
Araújo RAC, Anagusko CLY, Morato Castro PL, Ventura AKRM, Castro FFM, Kalil Filho JE, Santos KS, Yang AC.   +7 more
europepmc   +1 more source

Validation of International Classification of Diseases Code–Based Case Definitions of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis From Administrative Health Data

Arthritis &Rheumatology, EarlyView.
Objective Immune checkpoint inhibitors (ICIs) for cancer can lead to immune‐related adverse events, including ICI‐associated inflammatory arthritis (ICI‐IA). There are no validated International Classification of Diseases (ICD) code–based case definitions for ICI‐IA.
Manar Elsayed, Zoe Hsu, Finlay A. McAlister, William D. Leslie, Lisa M. Lix, Sasha Bernatsky, Suzanne N. Morin, Michelle M. Graham, Aurore Fifi‐Mah, Shahin Jamal, Janet Roberts, Carrie Ye   +11 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Irradiation does not impact the immunogenicity of food flours used for oral immunotherapy. [PDF]

J Allergy Clin Immunol Glob
Moran TP, Penumarti A, Immormino RM, Northup T, Guo R, Kesselring J, Turner A, Mathai P, Humphrey JR, Smeekens JM, Kim EH, Virkud YV, Fulkerson PC, Kulis MD.   +13 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Peanut Oral Immunotherapy in Children: An Italian Single-Center Retrospective Cohort Study. [PDF]

Nutrients
Pessina B, Sertori C, Barni S, Catamerò F, Liccioli G, Paladini E, Sarti L, Tomei L, Upton J, Valleriani C, Mori F, Giovannini M.   +11 more
europepmc   +1 more source

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum, Milli McMenamin, Tessa Khoo, John M. Edwin, Prathibha Jose, Liam A. O’Callaghan   +5 more
wiley   +1 more source

Hazelnut oral immunotherapy in children: An Italian single-center retrospective cohort study. [PDF]

Pediatr Allergy Immunol
Barni S, Pessina B, Della Femina S, Catamerò F, Valleriani C, Giovannini M, Liccioli G, Sarti L, Tomei L, Mori F.   +9 more
europepmc   +1 more source